Overview of research groups connected to DCMN. You can filter the list with regards to research theme and research department.
Benno Roozendaal's research investigates the brain processes underlying the effects of emotional arousal on memory processes. The goal is to increase understanding of traumatic memories in humans and develop new strategies for the prevention or treatment of memory- and anxiety disorders.
Cerebral circulation and cognition: Translational neurosciene
Amanda Kiliaan’s research group uses a multidisciplinary approach to study the link between (cerebro)vascular disorders and neurodegeneration. Within this group, neuroimaging is an important tool to study aspects of cerebral hemodynamics (e.g. cerebral blood flow/volume, vasoreactivity).
Tjitske Kleefstra's aim is to improve care and management of rare genetic neurodevelopmental disorders (NDs) by constructing a concept of personalized healthcare. We aim to better understand the underlying neurocognitive and biological mechanisms to further investigate new therapeutic interventions.
Cognitive and affective neuroscience
Erno Hermans's group investigates how neurochemicals affect diverse cognitive functions, such as vigilance, executive function, and memory. Moreover, they study how stressful experiences alter the intrinsic neural dynamics in the brain and how such processes contribute to memory.
Cognitive neuroscience of memory and emotion
Guillén Fernández aims to gain insights into the declarative memory system, a network of brain structures that enables us to remember events and facts. Particularly, we focus on memory formation, consolidation and retrieval and interaction between memory, and other domains, like stress and emotion.
Indira Tendolkar's group focuses the intersection between clinical psychiatry and cognitive neuroscience with a focus on declarative memory. We investigate the adapatation of emotional and neutral memory processes depending on genetic and environmental variablity including somatic challenges.
Disorders in impulse- and aggression regulation
Robbert-Jan Verkes's group aims to understand the neurobiological impairments in individuals with disorders in impulse- and/or aggression control. Particular interest in the influence on impulsive behavior of psychotropic compounds, including the individual differences in the effects of these drugs.
Drosophila models of brain disorders and neurogenetics
Annette Schenck's research focuses on dissecting molecular networks and mechanisms underlying human brain function and disease. In order to be able to investigate the large number of genes, we use a powerful genetic model organism, the fruitfly Drosophila melanogaster.
Establishing physiological biomarkers of perioperative stress
Jurgen Fütterer's group conducts imaging and cognitive research at the intersection between clinical psychiatry and cognitive neuroscience with a focus forms of declarative memory that also play a role in development and maintenance of stress-related mental disorders.
Gene regulatory network models for brain disorders
Kees Albers's research group is focused on the integration of computational and experimental approaches to understand how genetic variation causes disease. In particular we try to understand how dysregulation of gene expression may cause disorders of the brain.
Macular degeneration and ophthalmogenetics
Carel Hoyng's research group specializes in studying the genetics of retinal disorders. The two main research activities are age-related macular degeneration , a research program which has been started to develop better visual rehabilitation, and Ophthalmogenetics.
Neurological movement disorders
Bas Bloem's first research line aims at studying human motor control in health and disease, in particular patients with neurological movement disorders. A second main interest is in health care innovation, aiming to develop and scientifically evaluate patient-centred collaborative care.
Jeroen Klevering's group founded the RP5000 consortium, a collaboration between ophthalmologists and geneticists in the Netherlands. In preparation of future clinical trials, they are developing and implementing new imaging techniques for the comprehensive functional assessment of the retina.